Recurrent Disease

Source: Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: July 5, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment Option Overview for Paranasal Sinus and Nasal Cavity Cancer

Patients with recurrent disease should consider chemotherapy clinical trials. Chemotherapy for recurrent squamous cell cancer of the head and neck has been shown to be efficacious as palliation and may improve a patient's quality of life and length of survival. Various drug combinations, including cisplatin, fluorouracil, and methotrexate, are effective.[8,9]

Source links and citations

Treatment of tumors of the paranasal sinuses and of the nasal cavity should be planned on an individual basis because of the complexity involved.

Continue within this section

Fluorouracil dosing →

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice